PL424007A1 - Composition that includes plant extracts - Google Patents
Composition that includes plant extractsInfo
- Publication number
- PL424007A1 PL424007A1 PL424007A PL42400717A PL424007A1 PL 424007 A1 PL424007 A1 PL 424007A1 PL 424007 A PL424007 A PL 424007A PL 42400717 A PL42400717 A PL 42400717A PL 424007 A1 PL424007 A1 PL 424007A1
- Authority
- PL
- Poland
- Prior art keywords
- composition
- plant extracts
- includes plant
- mixture
- extracts
- Prior art date
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Abstract
Kompozycja zawierająca mieszaninę ekstraktów roślinnych, znamienna tym, że zawiera mieszaninę ekstraktów z tymianku właściwego, rumianku pospolitego oraz lebiodki pospolitej. Zgłoszenie obejmuje także preparat leczniczy charakteryzujący się tym, że zawiera przedmiotową kompozycję.A composition containing a mixture of plant extracts, characterized in that it contains a mixture of extracts of thyme, chamomile and marjoram. The application also includes a medicinal preparation characterized in that it comprises the subject composition.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL424007A PL238162B1 (en) | 2017-12-22 | 2017-12-22 | Composition that includes plant extracts |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL424007A PL238162B1 (en) | 2017-12-22 | 2017-12-22 | Composition that includes plant extracts |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL424007A1 true PL424007A1 (en) | 2019-07-01 |
| PL238162B1 PL238162B1 (en) | 2021-07-12 |
Family
ID=67105478
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL424007A PL238162B1 (en) | 2017-12-22 | 2017-12-22 | Composition that includes plant extracts |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL238162B1 (en) |
-
2017
- 2017-12-22 PL PL424007A patent/PL238162B1/en unknown
Non-Patent Citations (3)
| Title |
|---|
| "A1ternatywne substancje w leczeniu eradykacyjnym Helicobacter pylori", BIOTECHNOLOGIA.PL, 6 February 2014 (2014-02-06), Retrieved from the Internet <URL:http://biotechnologia.pl/farmacja/alternatywne-substancje-w-Ieczeniu-eryadykacyjnym-helicobacter-pylori.13623> * |
| "Mieszanka ziół HELI na schorzenia wywołane bakterią Helicobacter pylori zawierająca m. inn. Chamomilla rumianek i Thymus tymianek aktualnie W sprzedaży", ZIOLKO-LUBLIN.PL, Retrieved from the Internet <URL:http://www.ziolko-lublin.pl/22.mieszanka-heli-50g.html> * |
| HERCULES SAKKAS, CHRISSANTHY PAPADOPOULOU, ANTIMICROBIAL ACTIVITY Y OF BASII OREGANO AND THYME ESSENTIAL OILS, 2017 * |
Also Published As
| Publication number | Publication date |
|---|---|
| PL238162B1 (en) | 2021-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL279015A (en) | Anti-interleukin-17a antibody, pharmaceutical composition thereof and use thereof | |
| IL270714A (en) | Liver organoid preparations, methods for their preparation and their uses | |
| MX2022010168A (en) | Calpain modulators and therapeutic uses thereof. | |
| EP3615659A4 (en) | Compositions and methods for the encapsulation and scalable delivery of agrochemicals | |
| PL3668937T3 (en) | Compositions and uses of z-1-chloro-2,3,3,3-tetrafluoroprop-1-ene | |
| FR3052453B1 (en) | PEPTIDE, COMPOSITION COMPRISING SAME AND USES IN PARTICULAR COSMETICS | |
| IL266017B (en) | Arylimidazolyl isoxazoles,their preparation,compositions and uses theroff | |
| FR3021319B1 (en) | PEPTIDES, COMPOSITIONS COMPRISING THE SAME, AND PARTICULARLY COSMETIC USES | |
| EP3309177A4 (en) | Pdl-1 antibody, pharmaceutical composition thereof, and uses thereof | |
| PH12018500029A1 (en) | Microbiome-compatible cosmetics | |
| MY191581A (en) | Anti-pd-1 antibodies | |
| EP3597735A4 (en) | Ctla4 antibody, pharmaceutical composition and use thereof | |
| MX421186B (en) | Antibody constructs | |
| IL273484A (en) | A33 antibody compositions and methods of using the same in radioimmunotherapy | |
| CO2019008103A2 (en) | Pharmaceutical compositions for combination therapy | |
| EP3714901A4 (en) | Lag-3 antibody pharmaceutical composition and use thereof | |
| PL3639845T3 (en) | Il-15 protein complex pharmaceutical composition and uses thereof | |
| FR3029915B1 (en) | TRIPEPTIDES, COMPOSITIONS COMPRISING THE SAME, AND USES IN PARTICULAR COSMETICS | |
| MX2017000676A (en) | ORITAVANCINA HIGH PURITY AND METHOD TO PRODUCE THE SAME. | |
| EP3632951A4 (en) | EPOXY RESIN, COMPOSITION COMPRISING EPOXY RESIN, AND HARDENED ARTICLE THEREOF | |
| ZA202000238B (en) | Sost antibody pharmaceutical composition and uses thereof | |
| IL263842A (en) | Tatk -cdkl5 fusion proteins, compositions, formulations, and use thereof | |
| ZA202106721B (en) | Pharmaceutical composition containing antibody against il-5 and use thereof | |
| MX2016017142A (en) | Allisartan isoproxil solid dispersion and pharmaceutical composition comprising same. | |
| PL3468964T3 (en) | Modulators of soce, compositions, and uses thereof |